NOACs in cancer associated thrombosis: managing anticoagulation in cancer patients in clinical practice
Event:
ESC CONGRESS 2019
Topic:
Cardiovascular Disease in Special Populations
Session type:
Satellite Symposium
Sponsored by Bayer AG
Date:
1 September 2019
Time:
13:00
-
14:00
Congress Session
5 presentations in this session
Introduction: how NOACs changed the practice in cancer-associated thrombosis
Speaker:
Professor S. Konstantinides (Mainz, DE)
From clinical trial to clinical recommendations: how to apply evidence into practice?
Speaker:
Doctor J. Weitz (Hamilton, CA)
Beyond real word evidence: learnings from databases and registers
Speaker:
Associate Professor J. Beyer-Westendorf (Dresden, DE)
Translating guidelines into clinical practice: when to use NOAC or LMWH?
Speaker:
Associate Professor P. Verhamme (Leuven, BE)
Closing remarks
Speaker:
Professor R. Bauersachs (Frankfurt am Main, DE)
5 speakers from this session
Professor Stavros V
Konstantinides
University Medical Center of Mainz, Mainz (Germany)
35
presentations
3
followers
Doctor Jeffrey
Weitz
Thrombosis & Atherosclerosis Research Institute (TaARI), Hamilton (Canada)
20
presentations
0
follower
Associate Professor Jan
Beyer-Westendorf
University Hospital "Carl Gustav Carus" Dresden, Center for Vascular Medicine, Dresden (Germany)
5
presentations
0
follower
Associate Professor Peter
Verhamme
Gasthuisberg University Hospital, Leuven (Belgium)
9
presentations
0
follower
Professor Rupert
Bauersachs
Cardioangiologic Center Bethanien, Frankfurt am Main (Germany)
4
presentations
0
follower
This platform is supported by
